PRKN and Alzheimer disease: Of note, in De Bastiani et al.’s study, PARK2 appeared to be repressed, thus suggesting a lowering of parkin expression/activity in AD (De Bastiani et al. bioRxiv, https://doi.org/10.1101/2021.06.09.447404).